Financhill
Sell
37

IMVT Quote, Financials, Valuation and Earnings

Last price:
$23.10
Seasonality move :
-10.57%
Day range:
$22.58 - $23.12
52-week range:
$12.72 - $29.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.70x
Volume:
829.6K
Avg. volume:
1.6M
1-year change:
-19.58%
Market cap:
$4B
Revenue:
--
EPS (TTM):
-$2.83

Earnings Data

Next earnings date for IMVT
Feb 05
2026
Most recent earnings per share
-$0.73
Missed by $0.00
(Nov 10/2025)
Consensus Estimate
-$0.73
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 -- -- -- -$0.70 --
11/10/2025 Q3 -- -- -$0.73 -$0.73 -$0.00
08/11/2025 Q2 -- -- -$0.71 -$0.67 -$0.03
05/28/2025 Q1 -- -- -$0.64 -$0.72 $0.08
02/06/2025 Q4 -- -- -$0.76 -$0.75 -$0.00
11/07/2024 Q3 -- -- -$0.75 -$0.61 -$0.14
08/06/2024 Q2 -- -- -$0.60 -$0.52 -$0.08
05/29/2024 Q1 -- -- -$0.52 -$0.43 -$0.09
02/12/2024 Q4 -- -- -$0.36 -$0.42 $0.06
11/09/2023 Q3 -- -- -$0.45 -- --
08/10/2023 Q2 -- -- -$0.57 -- --
05/22/2023 Q1 -- -- -$0.46 -- --
02/03/2023 Q4 -- -- -$0.49 -- --
11/04/2022 Q3 -- -- -$0.41 -- --
08/05/2022 Q2 -- -- -$0.35 -- --
06/08/2022 Q1 -- -- -$0.41 -- --
02/04/2022 Q4 -- -- -$0.36 -- --
11/05/2021 Q3 -- -- -$0.35 -- --
08/06/2021 Q2 -- -- -$0.31 -- --
06/01/2021 Q1 -- -- -$0.29 -- --
02/16/2021 Q4 -- -- -$0.32 -- --
11/12/2020 Q3 -- -- -$0.25 -- --
08/12/2020 Q2 -- -- -$0.38 -- --
06/29/2020 Q1 -- -- -$0.38 -- --
02/14/2020 Q4 -- -- -$0.28 -- --
09/30/2019 Q3 -- -- $0.01 -- --
08/12/2019 Q2 -- -- $0.01 -- --
06/12/2019 Q1 -- -- -$0.00 -- --

Immunovant, Inc. Earnings Questions

  • How Much did Immunovant, Inc. Generate in Revenue Last Quarter?

    Immunovant, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Immunovant, Inc. Beat Earnings Last Quarter?

    Immunovant, Inc. announced earnings per share of -$0.73 which represents a miss of analyst forecast a -$0.73 per share.

  • Is Immunovant, Inc. Profitable?

    Immunovant, Inc. reported -$105K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immunovant, Inc. EPS Next Year?

    Immunovant, Inc.'s earnings are forecast to decrease from -$2.73 per share to -$2.87 per share next year representing a decrease of -8.72%.

  • When is Immunovant, Inc.'s Earnings Date?

    Immunovant, Inc.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 31.68% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 45.78% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock